ArticlePLOS global public health2025
Countries' progress towards Global Health Security (GHS) increased health systems resilience during the Coronavirus Disease-19 (COVID-19) pandemic: A difference-in-difference study of 191 countries.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Structural gradients in excess mortality during and after the COVID-19 pandemic: economic development, preparedness, and cross-national differences, 2020-2024.Journal of global health · 2026Article
- Association of armed conflict and global measles cases: A structural equation modeling analysis of 193 countries from 2000 to 2023.PLoS medicine · 2026Article
- The impact of armed conflict on vaccination coverage: a systematic review of empirical evidence from 1985 to 2025.Conflict and health · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Research on health systems resilience during the Coronavirus Disease-2019 pandemic frequently used the Global Health Security Index (GHSI), a composite index scoring countries' health security and related capabilities. Conflicting results raised questions regarding the validity of the GHSI as a reliable index. This study attempted to better characterize when and to what extent countries' progress towards Global Health Security (GHS) augments health systems resilience. We used longitudinal data from 191 countries and a difference-in-difference (DiD) causal inference strategy to quantify the effect of countries' GHS capacity as measured by the GHSI on their coverage rates for essential childhood immunizations, a previously established proxy for health systems resilience. Using a sliding scale of cutoff values with step increments of one, we divided countries into treatment and control groups and determined the lowest GHSI score at which a safeguarding effect was observed. All analyses were adjusted for potential confounders. World Bank governance indicators were employed for robustness tests. While countries with overall GHSI scores of 57 and above prevented declines in childhood immunization coverage rates from 2020-2022 (coef: 0.91; 95% CI: 0.41-1.41), this safeguarding effect was strongest in 2021 (coef: 1.23; 95% CI: 0.05-2.41). Coefficient sizes for overall GHSI scores were smaller compared to several GHSI sub-components, including countries' environmental risks (coef: 4.28; 95% CI: 2.56-5.99) and emergency preparedness and response planning (coef: 1.82; 95% CI: 0.54-3.11). Our findings indicate that GHS was positively associated with health systems resilience during the pandemic (2020) and the following two years (2021-2022), that GHS may have had the most significant protective effects in 2021 as compared with 2020 and 2022, and that countries' underlying characteristics, including governance quality, bolstered health systems resilience during the pandemic.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.